3-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline, 97.0%, 25g

Ethyl 4-(3-methoxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate, 95.0%, 5g

4-Methoxy-2,3-dimethylphenol, 97%, 500mg

4,4',4'',4'''-Methanetetrayltetraaniline, 95.0%, 250mg

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g

2-Bromo-1-nitro-4-(trifluoromethyl)benzene, 95.0%, 5g

tert-Butyl N-methyl-N-[3-(methylamino)propyl]carbamate, 95.0%, 5g

Methyl (1r,4r)-4-(bromomethyl)cyclohexane-1-carboxylate, 98%, 5g

4-Hydroxyisobenzofuran-1,3-dione, 97.00%, 5g

Colonna capillare per GC ROTI®Cap-1, 30 m, 0.32 mm, 3.00 µm, 1 Pezzo(i)

Tetrakis(4-acetylphenyl)methane, 97%, 250mg

1-(1,3-thiazol-2-yl)-1H-pyrrole-2-carbaldehyde, 95.0%, 100mg

2-(Difluoromethyl)-1-fluorobenzene, 96.0%, 1g